VIEWS: 33 PAGES: 3 CATEGORY: Other POSTED ON: 11/2/2012
RnR Market Research analysis titled “Isothermal Nucleic Acid Amplification Technologies (INAAT)” discloses the promising trends in Nucleic acid testing and their applications in molecular diagnostics and laboratory research on a global scale. The World Health Organization (WHO) proposes that, an ideal diagnostic test that is suitable for developing countries, should be Affordable, Sensitive, Specific and User-friendly (simple to perform in a few steps with minimal training), Robust and rapid (results available in minutes), Equipment free and Deliverable to the end user (ASSURED).
RnR Market Research Offers “Isothermal Nucleic Acid Amplification Technologies Market (2012-2017) (Molecular diagnostics, infectious disease testing, blood screening, cancer research, rapid testing)“Report at US$ 4650 (Single User License). The report got published in Oct 2012. The research analysis titled “Isothermal Nucleic Acid Amplification Technologies (INAAT)” discloses the promising trends in Nucleic acid testing and their applications in molecular diagnostics and laboratory research on a global scale. The World Health Organization (WHO) proposes that, an ideal diagnostic test that is suitable for developing countries, should be Affordable, Sensitive, Specific and User-friendly (simple to perform in a few steps with minimal training), Robust and rapid (results available in minutes), Equipment free and Deliverable to the end user (ASSURED). Nucleic acid amplification tests targeting pathogen markers have high sensitivity and specificity, but generally fail to meet the ASSURED guidelines in terms of affordability, rapidity, and being equipment free. However, INAAT has recently attracted the scientific community due to their operation in single temperature and distinct features by meeting the ASSURED guidelines. With fine-tunings in the amplification methodology, a variety of INAAT types are discovered each being independent, driving the diagnostic platform towards Point-Of-Care (POC) testing at low resource settings. This research report provides in-depth details about technology evolution, and innovation trends across the industry, technology investment potential and competitive market landscape. The analyses ensuing out of this research service may provide, useful insights for end users, while prioritizing the appropriate choice of modality for nucleic acid testing in research and diagnostics. Get your copy of this report @ http://www.rnrmarketresearch.com/isothermal-nucleic-acid- amplification-technologies-market-2012-2017-molecular-diagnostics-infectious-disease- testing-blood-screening-cancer-research-rapid-testing-market-report.html In brief, this research report provides: A detailed description of the global technology developments and evolving trends, in the INAAT field with key prominence on product innovations by industries, and collaborative efforts by the academic research institutions. A comprehensive picture of the different types of INAAT platforms available with an exhaustive overview of their application prospective. An impact analysis of major drivers, restraints and challenges influencing the adoption and growth of INAAT during the period from 2012 to 2017. Market size – Global market forecast for the next 5 years, including demand side analysis and strategic recommendations for technology/product developers. Prioritized INNAT types through the Analytical Hierarchy Process (AHP) based on competitive benchmarking, technology management strategies and technology roadmap. Competitive landscape based on the analysis of key patents and research publications that gives an insight into prominent activities and global participants. Main Driver: Global prevalence of infections and cancer: An effective diagnosis of diseases is the first step towards personalized medicine. Over 1 billion people are afflicted owing to infectious diseases and cancer especially in the tropical/developing countries where access to diagnostics labs are limited. Main Restraint: Conservative mindset for INAAT usage: Most of the end users perceive PCR to be more reliable standard for detection. This is true for some of the developing and developed countries. Owing to the lack of knowledge or awareness about the advances in the latest technological developments in INAAT. This is perceived as a restraint for INAAT market Main Challenge: Market penetration of INAAT: Penetrating new markets in China, India and Middle could be competitive for INAAT based players due to high competition from players who are already suppliers of PCR based products. However this could be a big advantage for PCR diagnostic product manufacturers, since they have capability to adopt these new technologies. Table of Contents 1 Introduction 1.1 Key Take-Aways 1.2 Report Scope 1.3 Research Methodology 1.4 Key Data Sources 2 Executive Summary 3 Isothermal Nucleic Acid Amplification Technologies (INAAT) – Technology Landscape Analysis 3.1 Technology Overview 3.2 INAAT Vs Conventional Methods – Competitive Advantages 3.3 Technology Value Chain Analysis 3.4 Comparative Analysis Of INAAT Types 3.5 Applications 3.5.1 INAAT - Molecular Diagnostics 184.108.40.206. Infectious Disease Diagnostics 220.127.116.11. Blood Screening 3.5.2 INAAT - Research Applications 18.104.22.168 Laboratory Research 22.214.171.124 Cancer Research 3.6 Product/Technology Innovations - Applications 4 Technology Investment Potential 4.1 Investment Climate Assessment 4.1.1 Public Funding Bodies 4.1.2 Philanthropic Bodies 4.1.3 Private Investors & Venture Capital Firms 4.1.4 Insights On Current And Future Tech-Investment Trends 4.1.5 Some Of The Funds And Investments On INAAT 4.2 Investor Network 4.2.1 Investment Opportunities 126.96.36.199 Evaluation Of Technologies Available For Licensing & Acquisition For Stakeholders 188.8.131.52 Analysis Of Potential Application Areas For Technology Investment Using OSE Grid 5 INAAT - Market Landscape Analysis 5.1 Market Segmentation 5.2 INAAT Market Share In Molecular Diagnostics (MDX) 5.3 Global Market Forecast 5.3.1 By Geography 5.3.2 By Applications 5.4 Market Dynamics 5.4.1 Drivers 5.4.2 Restraints 5.4.3 Challenges 5.4.4 Current And Emerging Opportunities 5.5 Demand Side Analysis 6 INAAT – Technology Adoption Potential And Development By Geography 6.1 Technology Adoption & Development – Key Findings 6.2 North America 6.3 Europe 6.4 ASIA 6.5 Rest Of The World 6.6 Regions With High Technology Adoption 7 Competitive Landscape 7.1 Mergers & Acquisitions (2007-2012) 7.2 Partnerships & Collaborations (2007-2012) 7.3 New Product Development Initiatives – 2012 7.3.1 List of NEW approved INAAT products – 2012 7.3.2 INAAT products – IN Pipeline 7.3.3 Research Innovations 8 Patent Analysis And Research Trend (Publications) 2007-2012 8.1 Patent Landscape Analysis (2007-2012) 8.2 Research Landscape (2007-2012) 9 TECHNOLOGY ANALYSIS (USING AHP) AND ROAD MAPPING 10 Analyst Insights And Recommendations 10.1 Strategic Recommendations For Technology And Business Management 10.2 Key Invitations & Opportunities 11 Company Profiles 11.1 BECTON, DICKINSON AND COMPANY (BD) 11.2 BIOHELIX 11.3 BIOMERIEUX 11.4 EIKEN CHEMICAL CO., LTD. 11.5 HOLOGIC GEN-PROBE 11.6 LUCIGEN 11.7 MERIDIAN BIOSCIENCE INC 11.8 NEW ENGLAND BIOLABS 11.9 NOVARTIS DIAGNOSTICS 11.1 NUGEN 11.11 QIAGEN 11.12 TWISTDX 11.13 USTAR BIOTECHNOLOGIES (HANGZHOU) LTD. 12 Appendix 13 Glossary For more details contact Mr. Priyank Tiwari: email@example.com / +18883915441 Website: http://www.rnrmarketresearch.com/
Pages to are hidden for
"2012 to 2017 Isothermal Nucleic Acid Amplification Technologies Market Research Report on Molecular diagnostics, infectious disease testing, blood screening, cancer research, rapid testing"Please download to view full document